These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 26211592)
1. Inhibition of c-Myc by 10058-F4 induces growth arrest and chemosensitivity in pancreatic ductal adenocarcinoma. Zhang M; Fan HY; Li SC Biomed Pharmacother; 2015 Jul; 73():123-8. PubMed ID: 26211592 [TBL] [Abstract][Full Text] [Related]
2. Therapeutic effects of an anti-Myc drug on mouse pancreatic cancer. Stellas D; Szabolcs M; Koul S; Li Z; Polyzos A; Anagnostopoulos C; Cournia Z; Tamvakopoulos C; Klinakis A; Efstratiadis A J Natl Cancer Inst; 2014 Dec; 106(12):. PubMed ID: 25306215 [TBL] [Abstract][Full Text] [Related]
3. Verteporfin suppresses cell survival, angiogenesis and vasculogenic mimicry of pancreatic ductal adenocarcinoma via disrupting the YAP-TEAD complex. Wei H; Wang F; Wang Y; Li T; Xiu P; Zhong J; Sun X; Li J Cancer Sci; 2017 Mar; 108(3):478-487. PubMed ID: 28002618 [TBL] [Abstract][Full Text] [Related]
4. Induction of cell death in pancreatic ductal adenocarcinoma by indirubin 3'-oxime and 5-methoxyindirubin 3'-oxime in vitro and in vivo. Sano M; Ichimaru Y; Kurita M; Hayashi E; Homma T; Saito H; Masuda S; Nemoto N; Hemmi A; Suzuki T; Miyairi S; Hao H Cancer Lett; 2017 Jul; 397():72-82. PubMed ID: 28347789 [TBL] [Abstract][Full Text] [Related]
5. Targeting PIN1 exerts potent antitumor activity in pancreatic ductal carcinoma via inhibiting tumor metastasis. Chen L; Xu X; Wen X; Xu S; Wang L; Lu W; Jiang M; Huang J; Yang D; Wang J; Zheng M; Zhou XZ; Lu KP; Liu H Cancer Sci; 2019 Aug; 110(8):2442-2455. PubMed ID: 31148345 [TBL] [Abstract][Full Text] [Related]
6. Hedgehog inhibitor decreases chemosensitivity to 5-fluorouracil and gemcitabine under hypoxic conditions in pancreatic cancer. Onishi H; Morifuji Y; Kai M; Suyama K; Iwasaki H; Katano M Cancer Sci; 2012 Jul; 103(7):1272-9. PubMed ID: 22486854 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of the Hedgehog pathway induces autophagy in pancreatic ductal adenocarcinoma cells. Xu Y; An Y; Wang X; Zha W; Li X Oncol Rep; 2014 Feb; 31(2):707-12. PubMed ID: 24297612 [TBL] [Abstract][Full Text] [Related]
8. DFMO Improves Survival and Increases Immune Cell Infiltration in Association with MYC Downregulation in the Pancreatic Tumor Microenvironment. Nakkina SP; Gitto SB; Beardsley JM; Pandey V; Rohr MW; Parikh JG; Phanstiel O; Altomare DA Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34947972 [TBL] [Abstract][Full Text] [Related]
9. Preclinical pharmacodynamic evaluation of a new Src/FOSL1 inhibitor, LY-1816, in pancreatic ductal adenocarcinoma. Yang W; Meng L; Chen K; Tian C; Peng B; Zhong L; Zhang C; Yang X; Zou J; Yang S; Li L Cancer Sci; 2019 Apr; 110(4):1408-1419. PubMed ID: 30618127 [TBL] [Abstract][Full Text] [Related]
10. Important roles of estrogen receptor alpha in tumor progression and anti-estrogen therapy of pancreatic ductal adenocarcinoma. Xue J; Yao Y; Yao Q; Tian X; Feng Y; Su H; Kong D; Cui C; Yan L; Hao C; Zhou T Life Sci; 2020 Nov; 260():118302. PubMed ID: 32827543 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of renalase expression and signaling has antitumor activity in pancreatic cancer. Guo X; Hollander L; MacPherson D; Wang L; Velazquez H; Chang J; Safirstein R; Cha C; Gorelick F; Desir GV Sci Rep; 2016 Mar; 6():22996. PubMed ID: 26972355 [TBL] [Abstract][Full Text] [Related]
12. The c-MYC-ABCB5 axis plays a pivotal role in 5-fluorouracil resistance in human colon cancer cells. Kugimiya N; Nishimoto A; Hosoyama T; Ueno K; Enoki T; Li TS; Hamano K J Cell Mol Med; 2015 Jul; 19(7):1569-81. PubMed ID: 25689483 [TBL] [Abstract][Full Text] [Related]
13. Enhanced Anti-tumor Effect of Flavopiridol in Combination With Gemcitabine in Pancreatic Cancer. Chung KH; Cho IR; Paik WH; Kim YT; Lee SH; Ryu JK Anticancer Res; 2024 Mar; 44(3):1097-1108. PubMed ID: 38423644 [TBL] [Abstract][Full Text] [Related]
14. A study of the suppressive effect on human pancreatic adenocarcinoma cell proliferation and angiogenesis by stable plasmid-based siRNA silencing of c-Src gene expression. Zhao X; Li DC; Zhao H; Li Z; Wang JX; Zhu DM; Zhou J; Cen JN Oncol Rep; 2012 Mar; 27(3):628-36. PubMed ID: 22200682 [TBL] [Abstract][Full Text] [Related]
15. Small-molecule c-Myc inhibitor, 10058-F4, inhibits proliferation, downregulates human telomerase reverse transcriptase and enhances chemosensitivity in human hepatocellular carcinoma cells. Lin CP; Liu JD; Chow JM; Liu CR; Liu HE Anticancer Drugs; 2007 Feb; 18(2):161-70. PubMed ID: 17159602 [TBL] [Abstract][Full Text] [Related]
16. Histone deacetylase class-I inhibition promotes epithelial gene expression in pancreatic cancer cells in a BRD4- and MYC-dependent manner. Mishra VK; Wegwitz F; Kosinsky RL; Sen M; Baumgartner R; Wulff T; Siveke JT; Schildhaus HU; Najafova Z; Kari V; Kohlhof H; Hessmann E; Johnsen SA Nucleic Acids Res; 2017 Jun; 45(11):6334-6349. PubMed ID: 28369619 [TBL] [Abstract][Full Text] [Related]
17. In vitro and in vivo anticancer efficacy of silibinin against human pancreatic cancer BxPC-3 and PANC-1 cells. Nambiar D; Prajapati V; Agarwal R; Singh RP Cancer Lett; 2013 Jun; 334(1):109-17. PubMed ID: 23022268 [TBL] [Abstract][Full Text] [Related]
18. Nicotine promotes initiation and progression of KRAS-induced pancreatic cancer via Gata6-dependent dedifferentiation of acinar cells in mice. Hermann PC; Sancho P; Cañamero M; Martinelli P; Madriles F; Michl P; Gress T; de Pascual R; Gandia L; Guerra C; Barbacid M; Wagner M; Vieira CR; Aicher A; Real FX; Sainz B; Heeschen C Gastroenterology; 2014 Nov; 147(5):1119-33.e4. PubMed ID: 25127677 [TBL] [Abstract][Full Text] [Related]